Creating effective strategies to mitigate risk and enable prompt remediation of viral, prion and mycoplasma contamination

Come away with fresh ideas on:

• Implementing the latest techniques to screen for mycoplasma and mitigate your risk of contamination with Roche
• Performing risk assessments to avoid TSE contamination at your facility with AFSSAPS
• Creating a contingency plan for remediation in case of contamination at your facility with Eli Lilly
• Best-practice approaches to dealing with actual contaminations from Genzyme and Merrimack – apply their lessons to your organisation
• Ensuring the safety of your raw materials with CSL Behring – get that vital first step right!

Download The Full Programme Here

In the wake of recent contaminations at companies like Genzyme in 2009 and GSK last year, all biologics producers must arm themselves with the information and tactics necessary to avoid contamination—or, in a worst-case scenario, to contain and recover from a contamination as quickly as possible.

Building on the success of last year’s Viral Safety event, Pharma IQ’s 2nd Annual Ensuring Adventitious Agents and Viral Safety in Biologics conference will provoke discussion between industry professionals and facilitate the development of the tools and strategies you need to ensure the safety of your biologics and protect your GMP facility. This event will provide an interactive forum for learning best practices, keeping abreast of new developments and forging lasting business relationships.

Join us this October in Munich to learn from biotech and biopharma experts—and one another—how to escape contamination and get your products to market safely, speedily and successfully.